HOME >> MEDICINE >> NEWS
New evidence about positive three-tier co-pay performance presented at Express Scripts 2000 Outcomes Conference

Researcher first to study and report on prescription drug benefit tool

ST. LOUIS, June 28, 2000 -- Researcher Brenda Motheral, PhD, told participants of the fourth annual Express Scripts (NASD: ESRX) Outcomes Conference, held in St. Louis, that recent data indicates three-tier co-pay prescription programs have enjoyed a great deal of success since their inception two years ago.

Motheral, the author of numerous articles in the area of outcomes research, claims database methodology and managed care, conducted the first study within the healthcare industry that documents how implementation of a three-tier prescription co-pay plan affects pharmaceutical and medical utilization and expenditures, continuation with chronic medications and the percent of enrollees affected.

She told conference participants that the relatively new co-pay structure can significantly lower payers' trend in pharmaceutical expenditures, and members are not showing evidence of medication noncompliance, as was expected by some industry experts when the three-tier medication co-pay structure was initiated three years ago.

Motheral and co-investigator, Kathi Fairman, studied two comparable preferred provider organization (PPO) groups located in the same state. The plans had nearly identical demographic profiles in terms of age, gender and incidence of chronic illness.

Group one instituted a three-tier co-pay plan in 1998, changing from a two-tier plan with a $7/$12 co-pay structure to a co-pay structure of $8/$15/$25, depending on the tier level. For the year preceding implementation, drugs that were placed on tier three (brand name/non-formulary) constituted 14 percent of prescription claims.

Group two, the control group, maintained its $7/$12 two-tier structure for the duration of the study.

The study substantiated the claim that a three-tier structure can significantly lower plan sponsors' trend in pharmaceu
'"/>

Contact: Ryan Soderstrom
rsoderst@express-scripts.com
612-837-5160
Kupper Parker Communications
27-Jun-2000


Page: 1 2 3 4 5

Related medicine news :

1. More evidence of cannabis-induced psychosis
2. Not enough evidence that multivitamins prevent infections in the elderly
3. Emotional memory study reveals evidence for a self-reinforcing loop
4. Influenza vaccination programmes for children in USA and Canada based on little evidence
5. Scientific evidence for diets: dont believe everything you read
6. New evidence of retroviral involvement in amyotrophic lateral sclerosis
7. Two studies find evidence that sunlight may have beneficial influence on cancer
8. Study finds no evidence of a cancer personality
9. Penn researchers add more evidence to demonstrate role of COX inhibitors in heart-disease risk
10. USC researchers find evidence that progesterone signaling influences ovarian cancer risk
11. Chamomile tea: New evidence supports health benefits

Post Your Comments:
(Date:5/30/2015)... “ Milli the Snail ” was featured ... a look at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... engages and educates children. , Interactive mobile games for children ... content and games they are playing are doing much for ...
(Date:5/29/2015)... Montclair, NJ (PRWEB) May 30, 2015 ... and ever changing local and federal regulations, we ... needs of their patients who are suffering from ... regulations,” says Srinivas Nalamachu, MD, professor of rehabilitation ... Research Institute in Overland Park, Kansas. , A ...
(Date:5/29/2015)... 29, 2015 M3 USA MDLinx.com, source ... 14 medical specialties, now offers The Smartest Rheumatologist ... of rheumatology disorders ranging from Fibromyalgia and Osteoporosis, to ... director of MDLinx, and Caroline Tredway, editorial head of ... it will have on the physicians who participate. Says ...
(Date:5/29/2015)... May 29, 2015 The science of ... last decade. New and more efficient methods of FUE hair ... balding patients. One of the most cutting edge hair transplant ... Restoration is the technique of extracting hair from the beard ... are performed to correct male pattern baldness. Beard ...
(Date:5/29/2015)... Jan Wooden Howse lost her husband and ... all else: God does no wrong. , It’s fitting, then, ... passing is titled “God Does No Wrong.” It focuses on ... personal tragedy. , “My story has a positive message ... into something productive, something healing,” Howse said. , “God Does ...
Breaking Medicine News(10 mins):Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Turning grief from a child’s passing into virtue 2
(Date:5/29/2015)... May 29, 2015 Actinobac Biomed, NovoPedics, Inc. ... with investments from Foundation Venture Capital Group (FVCG), have ... 2015 as part of the Start-Up Stadium and Company ... James M. Golubieski . The ... will be held in Philadelphia ...
(Date:5/29/2015)... 29, 2015 Eli Lilly and Company (NYSE: ... Annual Global Healthcare Conference on Tuesday, June 9, 2015. ... Elanco Animal Health, will participate in a fireside chat ... A live audio webcast will be available on the ... http://investor.lilly.com/events.cfm . A replay of the fireside chat ...
(Date:5/29/2015)... and SPARTANBURG, South Carolina ... Guardian Research Network and Molecular Health have announced a ... molecular diagnostic decision support to the majority of cancer ... Research Network will collaborate with Molecular Health to harness ... to identify cohorts from hundreds of thousands of patients ...
Breaking Medicine Technology:Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3Lilly to Participate in Goldman Sachs Global Healthcare Conference 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
Cached News: